Retatrutide

Retatrutide  is a triple receptor agonist meaning it activates three key hormone pathways that play a role in glucose metabolism and appetite regulation:
Glucagon-like peptide-1 (GLP-1) receptor – involved in insulin secretion, appetite suppression, and slowing digestion.
Glucose-dependent insulinotropic polypeptide (GIP) receptor – enhances insulin release in response to food intake and may contribute to weight loss.
Glucagon receptor – plays a role in energy expenditure and fat metabolism.
Retatrutide is taken as a once-weekly subcutaneous injection. One vial per month.